STAT3 and hepatocellular carcinoma: In addition, it was found that OCT4 can be upregulated by stimulating STAT3/DNA methyltransferases (DNMTs), and inhibiting DNMTs can increase sensitivity to sorafenib in HCC cell lines and in animal models [139].